Energy Failure

Energy failure from mitochondrial dysfunction is proposed to be a central mechanism leading to neuronal death in a range of neurodegenerative diseases. However, energy failure has never been directly demonstrated in affected neurons in these diseases, nor has it been proved to produce degeneration in disease models. Therefore, despite considerable indirect evidence, it is not known whether energy failure truly occurs in susceptible neurons, and whether this failure is responsible for their death. This limited understanding results primarily from a lack of sensitivity and resolution of available tools and assays and the inherent limitations of in vitro model systems. Major advances in these methodologies and approaches should greatly enhance our understanding of the relationship between energy failure, neuronal dysfunction, and death, and help us to determine whether boosting bioenergetic function would be an effective therapeutic approach. Here we review the current evidence that energy failure occurs in and contributes to neurodegenerative disease, and consider new approaches that may allow us to better address this central issue. Ann Neurol 2013;74:506–516

[1]  Xiongwei Zhu,et al.  LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. , 2012, Human molecular genetics.

[2]  R. Youle,et al.  Parkin is recruited selectively to impaired mitochondria and promotes their autophagy , 2008, The Journal of cell biology.

[3]  R. Youle,et al.  Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin , 2010, The Journal of cell biology.

[4]  M. Feany,et al.  Tau Promotes Neurodegeneration via DRP1 Mislocalization In Vivo , 2012, Neuron.

[5]  A. Chiarugi “Simple but not simpler”: toward a unified picture of energy requirements in cell death , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  R. Rodenburg,et al.  Depletion of PINK1 affects mitochondrial metabolism, calcium homeostasis and energy maintenance , 2011, Journal of Cell Science.

[7]  Rodrigue Rossignol,et al.  Energy Substrate Modulates Mitochondrial Structure and Oxidative Capacity in Cancer Cells , 2004, Cancer Research.

[8]  D M Porterfield,et al.  The self-referencing oxygen-selective microelectrode: detection of transmembrane oxygen flux from single cells. , 1999, The Journal of experimental biology.

[9]  P. E. Gold,et al.  Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Nobuhiko Ohno,et al.  Myelination and Axonal Electrical Activity Modulate the Distribution and Motility of Mitochondria at CNS Nodes of Ranvier , 2011, The Journal of Neuroscience.

[11]  D. Manners,et al.  Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy , 2000, Annals of neurology.

[12]  W. Lieberthal,et al.  Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. , 1998, American journal of physiology. Renal physiology.

[13]  R. Palmiter,et al.  Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson’s disease model , 2011, The Journal of cell biology.

[14]  A. Munnich,et al.  Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency , 2000, The Lancet.

[15]  Carola Seifried,et al.  Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease. , 2009, Brain : a journal of neurology.

[16]  G. Ronnett,et al.  Physiological oxygen level is critical for modeling neuronal metabolism in vitro , 2012, Journal of neuroscience research.

[17]  Arne Schousboe,et al.  Compartmentation of Glutamine, Glutamate, and GABA Metabolism in Neurons and Astrocytes: Functional Implications , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[18]  I. Reynolds,et al.  Mitochondrial Trafficking to Synapses in Cultured Primary Cortical Neurons , 2006, The Journal of Neuroscience.

[19]  P. Verstreken,et al.  Synaptic Mitochondria Are Critical for Mobilization of Reserve Pool Vesicles at Drosophila Neuromuscular Junctions , 2005, Neuron.

[20]  K. Kashihara Weight loss in Parkinson’s disease , 2006, Journal of Neurology.

[21]  Takeharu Nagai,et al.  Visualization of ATP levels inside single living cells with fluorescence resonance energy transfer-based genetically encoded indicators , 2009, Proceedings of the National Academy of Sciences.

[22]  M. J. Arnold,et al.  Glucose dependence of glycolysis, hexose monophosphate shunt activity, energy status, and the polyol pathway in retinas isolated from normal (nondiabetic) rats. , 1997, Investigative ophthalmology & visual science.

[23]  D. Blum,et al.  3‐Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease , 2005, Journal of neurochemistry.

[24]  Paul T. Schumacker,et al.  Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1 , 2010, Nature.

[25]  Atsushi Tanaka,et al.  PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin , 2010, PLoS biology.

[26]  Douglass M. Turnbull,et al.  Does the mitochondrial genome play a role in the etiology of Alzheimer’s disease? , 2006, Human Genetics.

[27]  Frederico A. C. Azevedo,et al.  Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled‐up primate brain , 2009, The Journal of comparative neurology.

[28]  Angela C. Poole,et al.  The PINK1/Parkin pathway regulates mitochondrial morphology , 2008, Proceedings of the National Academy of Sciences.

[29]  Manuel B. Graeber,et al.  PGC-1α, A Potential Therapeutic Target for Early Intervention in Parkinson’s Disease , 2010, Science Translational Medicine.

[30]  HighWire Press The journal of neuroscience : the official journal of the Society for Neuroscience. , 1981 .

[31]  John X. Morris,et al.  Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition , 2010, Proceedings of the National Academy of Sciences.

[32]  F Gonzalez-Lima,et al.  Energy Hypometabolism in Posterior Cingulate Cortex of Alzheimer's Patients: Superficial Laminar Cytochrome Oxidase Associated with Disease Duration , 2001, The Journal of Neuroscience.

[33]  H. Savolainen Dichloroacetate causes toxic neuropathy in MELAS: A randomized, controlled clinical trial , 2006, Neurology.

[34]  S. Koifman,et al.  Pesticide exposure and Parkinson's disease: epidemiological evidence of association. , 2012, Neurotoxicology.

[35]  L. Massieu,et al.  Neurotoxicity of glutamate uptake inhibition in vivo: correlation with succinate dehydrogenase activity and prevention by energy substrates , 2001, Neuroscience.

[36]  Xin Li,et al.  α-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity , 2009, Neuroscience Letters.

[37]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[38]  G. Brewer,et al.  Mitoenergetic failure in Alzheimer disease. , 2007, American journal of physiology. Cell physiology.

[39]  A. Schousboe,et al.  Novel model of neuronal bioenergetics: postsynaptic utilization of glucose but not lactate correlates positively with Ca2+ signalling in cultured mouse glutamatergic neurons , 2012, ASN neuro.

[40]  Ann Saada,et al.  The Transgenic Overexpression of α-Synuclein and Not Its Related Pathology Associates with Complex I Inhibition* , 2010, The Journal of Biological Chemistry.

[41]  J. Buxbaum,et al.  PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. , 2009, Archives of neurology.

[42]  F. Fujiyama,et al.  Single Nigrostriatal Dopaminergic Neurons Form Widely Spread and Highly Dense Axonal Arborizations in the Neostriatum , 2009, The Journal of Neuroscience.

[43]  Min Wu,et al.  Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. , 2007, American journal of physiology. Cell physiology.

[44]  J. Greene,et al.  Characterization of the Excitotoxic Potential of the Reversible Succinate Dehydrogenase Inhibitor Malonate , 1995, Journal of neurochemistry.

[45]  S. Moncada,et al.  The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C–Cdh1 , 2009, Nature Cell Biology.

[46]  Andrea Ciarmiello,et al.  Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[47]  N. Bonini,et al.  DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function , 2010, Proceedings of the National Academy of Sciences.

[48]  R. Burke,et al.  Clinical progression in Parkinson disease and the neurobiology of axons , 2010, Annals of neurology.

[49]  Changan Jiang,et al.  Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin , 2006, Nature.

[50]  M. Beal Faculty Opinions recommendation of S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. , 2009 .

[51]  R. Hamilton,et al.  Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.

[52]  S. Sisodiya,et al.  Mitochondrial ND5 Gene Variation Associated with Encephalomyopathy and Mitochondrial ATP Consumption* , 2007, Journal of Biological Chemistry.

[53]  D. Bennett,et al.  Change in body mass index and risk of incident Alzheimer disease , 2005, Neurology.

[54]  R. Nussbaum,et al.  Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein α-Synuclein*♦ , 2011, The Journal of Biological Chemistry.

[55]  J. Milbrandt,et al.  Mitofusin2 Mutations Disrupt Axonal Mitochondrial Positioning and Promote Axon Degeneration , 2012, The Journal of Neuroscience.

[56]  B. Landwehrmeyer,et al.  Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[57]  G. Shepherd,et al.  Three-Dimensional Structure and Composition of CA3→CA1 Axons in Rat Hippocampal Slices: Implications for Presynaptic Connectivity and Compartmentalization , 1998, The Journal of Neuroscience.

[58]  Douglas R. Porter,et al.  Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice , 2007, Proceedings of the National Academy of Sciences.

[59]  M. Beal,et al.  Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[60]  M. Beal,et al.  Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders , 2001, Annals of neurology.

[61]  George Perry,et al.  Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease , 2009, The Journal of Neuroscience.

[62]  J. Nunnari,et al.  Mitochondria: In Sickness and in Health , 2012, Cell.

[63]  K. Marder,et al.  Weight loss in early stage of Huntington’s disease , 2002, Neurology.

[64]  S. Dimauro,et al.  Phenotype–genotype correlations in skeletal muscle of patients with mtDNA deletions , 1995, Muscle & nerve. Supplement.

[65]  R. Palmiter,et al.  Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat , 2008, Proceedings of the National Academy of Sciences.

[66]  G. Petzinger,et al.  The parkinsonian toxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP): a technical review of its utility and safety , 2001, Journal of neurochemistry.

[67]  H. Engler,et al.  Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease , 2012, Neurobiology of Aging.

[68]  A. Godzik,et al.  S-Nitrosylation of Drp1 Mediates β-Amyloid-Related Mitochondrial Fission and Neuronal Injury , 2009, Science.

[69]  Robert W. Taylor,et al.  High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease , 2006, Nature Genetics.

[70]  Jens Frahm,et al.  Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity , 2012, Nature.

[71]  Sunhong Kim,et al.  Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin , 2006, Nature.

[72]  Kewei Chen,et al.  Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[73]  P. Verstreken,et al.  Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function , 2009, EMBO molecular medicine.

[74]  Janaka N. Edirisinghe,et al.  Vitamin K2 Is a Mitochondrial Electron Carrier That Rescues Pink1 Deficiency , 2012, Science.

[75]  C. Marsden,et al.  Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease , 1990, Journal of neurochemistry.

[76]  Xinnan Wang,et al.  PINK1 and Parkin Target Miro for Phosphorylation and Degradation to Arrest Mitochondrial Motility , 2011, Cell.

[77]  W. Frommer,et al.  GLUT1 and GLUT9 as major contributors to glucose influx in HepG2 cells identified by a high sensitivity intramolecular FRET glucose sensor. , 2008, Biochimica et biophysica acta.

[78]  H. Fox,et al.  Oxygen matters: tissue culture oxygen levels affect mitochondrial function and structure as well as responses to HIV viroproteins , 2011, Cell Death and Disease.

[79]  Fanny Mochel,et al.  Energy deficit in Huntington disease: why it matters. , 2011, The Journal of clinical investigation.

[80]  Pravat K. Mandal,et al.  Magnetic Resonance Spectroscopy (MRS) and Its Application in Alzheimer's Disease , 2007 .

[81]  A. Rex,et al.  Stimulus-dependent changes of extracellular glucose in the rat hippocampus determined by in vivo microdialysis , 2009, Physiology & Behavior.

[82]  A. Bacci,et al.  Lack of association between mtDNA haplogroups and Alzheimer’s disease in Tuscany , 2007, Neurological Sciences.

[83]  T. Dawson,et al.  PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease , 2011, Cell.

[84]  Winnie S. Liang,et al.  Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons , 2008, Proceedings of the National Academy of Sciences.

[85]  D. Chan,et al.  Disruption of Fusion Results in Mitochondrial Heterogeneity and Dysfunction* , 2005, Journal of Biological Chemistry.

[86]  T. Patterson,et al.  Gene expression profiling of MPP+-treated MN9D cells: a mechanism of toxicity study. , 2007, Neurotoxicology.

[87]  W. Watt,et al.  Mice with mitochondrial complex I deficiency develop a fatal encephalomyopathy. , 2008, Cell metabolism.

[88]  F. Schmitt,et al.  Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment , 2007, Neurology.

[89]  A. Ames,et al.  Energy metabolism of rabbit retina as related to function: high cost of Na+ transport , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[90]  B. Frenguelli,et al.  Mitochondrial Membrane Potential and Glutamate Excitotoxicity in Cultured Cerebellar Granule Cells , 2000, The Journal of Neuroscience.

[91]  Jim Berg,et al.  A genetically encoded fluorescent reporter of ATP/ADP ratio , 2008, Nature Methods.

[92]  Dimitri Krainc,et al.  Transcriptional Repression of PGC-1α by Mutant Huntingtin Leads to Mitochondrial Dysfunction and Neurodegeneration , 2006, Cell.

[93]  Michael R. Duchen,et al.  PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-Induced Cell Death , 2009, Molecular cell.

[94]  Shanta M. Messerli,et al.  Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase , 2011, Nature Cell Biology.

[95]  B R Rosen,et al.  1H NMR spectroscopy studies of Huntington's disease , 1998, Neurology.

[96]  Elsa Lauwers,et al.  Frontiers in Synaptic Neuroscience Synaptic Neuroscience , 2022 .

[97]  S. Snyder,et al.  Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[98]  J. Milbrandt,et al.  Aberrant Schwann Cell Lipid Metabolism Linked to Mitochondrial Deficits Leads to Axon Degeneration and Neuropathy , 2013, Neuron.

[99]  Victor S. Van Laar,et al.  The interplay of neuronal mitochondrial dynamics and bioenergetics: Implications for Parkinson's disease , 2013, Neurobiology of Disease.

[100]  Ted M. Dawson,et al.  PINK1-dependent recruitment of Parkin to mitochondria in mitophagy , 2009, Proceedings of the National Academy of Sciences.

[101]  Bradford C. Dickerson,et al.  Regional Expansion of Hypometabolism in Alzheimer's Disease Follows Amyloid Deposition with Temporal Delay , 2012, Biological Psychiatry.

[102]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[103]  R. Schiffmann,et al.  Early Alterations of Brain Cellular Energy Homeostasis in Huntington Disease Models* , 2011, The Journal of Biological Chemistry.

[104]  S. Przedborski,et al.  Is there a pathogenic role for mitochondria in Parkinson's disease? , 2009, Parkinsonism & related disorders.

[105]  Tamara Sotelo-Hitschfeld,et al.  High Resolution Measurement of the Glycolytic Rate , 2010, Front. Neuroenerg..

[106]  V. Choubey,et al.  Mutant A53T α-Synuclein Induces Neuronal Death by Increasing Mitochondrial Autophagy* , 2011, The Journal of Biological Chemistry.

[107]  M. Brand,et al.  Assessing mitochondrial dysfunction in cells , 2011, The Biochemical journal.

[108]  C. Schade-Brittinger,et al.  In vivo Evidence for Cerebral Depletion in High-Energy Phosphates in Progressive Supranuclear Palsy , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[109]  M. Walker,et al.  Prolonged seizure activity impairs mitochondrial bioenergetics and induces cell death , 2011, Journal of Cell Science.

[110]  Armin Giese,et al.  Inhibition of mitochondrial fusion by α‐synuclein is rescued by PINK1, Parkin and DJ‐1 , 2010, The EMBO journal.

[111]  Abnormal response to cortical activation in early stages of Huntington disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[112]  Thomas W von Geldern,et al.  Faculty Opinions recommendation of Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. , 2011 .

[113]  R. Margreiter,et al.  Heterogeneity of Mitochondria and Mitochondrial Function within Cells as Another Level of Mitochondrial Complexity , 2009, International journal of molecular sciences.

[114]  G. Alexander,et al.  Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism , 2005 .

[115]  H. Braak,et al.  Poor and protracted myelination as a contributory factor to neurodegenerative disorders , 2004, Neurobiology of Aging.

[116]  Janet S. Reddin,et al.  Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease , 2012, Alzheimer's & Dementia.

[117]  T. Videen,et al.  Selective defect of in vivo glycolysis in early Huntington's disease striatum , 2007, Proceedings of the National Academy of Sciences.

[118]  Dimitrios Kapogiannis,et al.  Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease , 2011, The Lancet Neurology.

[119]  L. Reitzer,et al.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. , 1979, The Journal of biological chemistry.

[120]  H. Westerblad,et al.  Increased mitochondrial mass in mitochondrial myopathy mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[121]  Jayne E. Telford,et al.  Complex I Is Rate-limiting for Oxygen Consumption in the Nerve Terminal* , 2009, Journal of Biological Chemistry.

[122]  H Li,et al.  Huntingtin Aggregate-Associated Axonal Degeneration is an Early Pathological Event in Huntington's Disease Mice , 2001, The Journal of Neuroscience.

[123]  W. Shan,et al.  Rapid method for culturing embryonic neuron–glial cell cocultures , 2003, Journal of neuroscience research.

[124]  A. Singleton,et al.  A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease. , 2009, American journal of human genetics.

[125]  J. Kordower,et al.  Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease. , 2012, Brain : a journal of neurology.

[126]  R. Nussbaum,et al.  Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.

[127]  M. Beal,et al.  Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery , 2008, Proceedings of the National Academy of Sciences.

[128]  S. Tabrizi,et al.  Biochemical abnormalities and excitotoxicity in Huntington's disease brain , 1999, Annals of neurology.

[129]  G. Sinclair,et al.  Guanidinoacetate methyltransferase deficiency: first steps to newborn screening for a treatable neurometabolic disease. , 2012, Molecular genetics and metabolism.

[130]  D. Turnbull,et al.  Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis. , 2011, Brain : a journal of neurology.

[131]  Ian J. Reynolds,et al.  Spontaneous Changes in Mitochondrial Membrane Potential in Cultured Neurons , 2001, The Journal of Neuroscience.